P670: EARLY CYTOGENETIC OR MOLECULAR LANDMARK RESPONSE TO PONATINIB TREATMENT PREDICTS OUTCOMES IN HEAVILY PRETREATED PATIENTS WITH CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA IN PACE:...

por Müller, Martin C., Cortes, Jorge, Chuah, Charles, Deangelo, Daniel, Deininger, Michael, Guilhot, François, Hughes, Timothy, Emmanuel Nicolini, Franck, Pinilla-Ibarz, Javier, Rea, Delphine, Rosti, Gianantonio, Shah, Neil P., Talpaz, Moshe, Lu, Vickie, Padukkavidana, Thihan, Kantarjian, Hagop
Publicado 2023

S155: PROGNOSTIC FACTORS FOR 3-YEAR MAJOR MOLECULAR RESPONSE MAINTENANCE IN CHRONIC MYELOID LEUKAEMIA PATIENTS IN THE EUROPEAN STOP KINASE INHIBITORS (EURO-SKI) TRIAL

por Pfirrmann, Markus, Mahon, Francois-Xavier, Dulucq, Stéphanie, Hochhaus, Andreas, Panayiotidis, Panayiotis, Almeida, Antonio, Mayer, Jiri, Hjorth-Hansen, Henrik, Janssen, Jeroen J. W. M., Mustjoki, Satu, Martinez-Lopez, Joaquín, Vestergaard, Hanne, Ehrencrona, Hans, Kairisto, Veli, Machová Poláková, Kateřina, Emmanuel Nicolini, Franck, Hofmann, Wolf-Karsten, Guilhot, Joëlle, Saussele, Susanne, Richter, Johan
Publicado 2023